Technology News and Research

RSS

STENTYS announces European commercial release of new Self-Apposing stent technology

STENTYS, a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today the European commercial release of an enhanced stent-delivery system for its Self-Apposing stent.

27 Sep 2012

Karolinska Institutet scientists discover new approach to treat type II diabetes

An international team of scientists, led from Karolinska Institutet in Sweden, have discovered an entirely new approach to the treatment of type II diabetes. The therapy involves the blockade of signalling by a protein known as VEGF-B and this prevents fat from accumulating in the 'wrong' places, such as in muscles and in the heart. As a result the cells within these tissues are once again able to respond to insulin.

27 Sep 2012

Loyola now offers sacral nerve stimulation for patients with fecal incontinence

Fecal incontinence, or the inability to control the bowels, is a highly underreported and stigmatized condition, according to colorectal surgeons at Loyola University Health System (LUHS).

27 Sep 2012

New optical imaging technology could aid in breast cancer diagnosis and treatment

New optical imaging technology developed at Tufts University School of Engineering could give doctors new ways to both identify breast cancer and monitor individual patients' response to initial treatment of the disease.

27 Sep 2012

Prime Healthcare Services purchases Dallas Medical Center

Prime Healthcare Services announced today that it has purchased Dallas Medical Center, located in Dallas, Texas.

27 Sep 2012

Journal of Vascular and Interventional Radiology debuts new iPad app

As tablet ownership trends away from early adopters and moves to the mainstream, the Journal of Vascular and Interventional Radiology has debuted a new app, available for iPad users, that will allow readers to access interventional radiology literature and multimedia—when they choose, ensuring fast, convenient access to up-to-the-minute peer-reviewed articles, podcasts, images and more.

27 Sep 2012

CTCA at Midwestern named Certified Quality Breast Center of Excellence

Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) has been recognized by the National Quality Measures for Breast Centers Program (NQMBC) as being among the top centers in the country for providing quality breast cancer care.

27 Sep 2012

NCI-funded sequencing project aims to identify genetic links to colorectal cancer

Uncovering colon cancer's genetic roots is the focus of a new $13 million, four-year, National Cancer Institute-funded project at Fred Hutchinson Cancer Research Center. Ulrike (Riki) Peters, Ph.D., M.P.H., a member of the Hutchinson Center's Public Health Sciences Division, will lead the effort. She and her colleagues will use next-generation sequencing, a technique that captures entire genome sequences, to identify genetic links to colorectal cancer.

27 Sep 2012

Alitair receives U.S. patent allowance for ion exchange resin formulation of benzonatate

Alitair Pharmaceuticals, Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its ion exchange resin formulation of benzonatate.

27 Sep 2012

Positive results from Sobi, Biogen Idec's rFIXFc Phase 3 trial on hemophilia B

Biogen Idec and Swedish Orphan Biovitrum (Sobi) today announced positive results from B-LONG, a clinical study that evaluated a new long-lasting clotting factor candidate in people with hemophilia B. Hemophilia B is a rare inherited disorder that impairs blood coagulation.

27 Sep 2012

Adult stem cells can prevent Alzheimer's disease

In the first study of its kind, researchers at Korea's leading university and the RNL Bio Stem Cell Technology Institute announced this week the results of a study that suggests an astounding possibility: adult stem cells may not only have a positive effect on those suffering from Alzheimer's disease, they can prevent the disease.

27 Sep 2012

NBSTRN develops new tool for newborn screening researchers

After one-and-a-half years of intense development, end-user testing, a successful pilot, and through a contract to the American College of Medical Genetics and Genomics (ACMG) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Newborn Screening Translational Research Network (NBSTRN) Coordinating Center has developed a centralized, web-based virtual repository of newborn dried blood spots (DBS) as an indispensable tool for newborn screening researchers.

27 Sep 2012

Landec first quarter revenues increase 39% to $102.1 million

Landec Corporation today reported results for the first quarter of fiscal year 2013 ended August 26, 2012. Revenues increased 39% to $102.1 million compared to revenues of $73.3 million for the first quarter a year ago. Net income increased 40% to $2.5 million or $0.10 per share compared to $1.8 million or $0.07 per share for the first quarter of last year.

27 Sep 2012

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients.

27 Sep 2012

Tips on safe use of opioids in hospitals

On August 8, The Joint Commission issued a Sentinel Event Alert on the safe use of opioids in hospitals. The Alert discussed the significance of accurate pain assessment and effective pain management plans.

26 Sep 2012

Retail Benefits acquires My HSA Rewards

Retail Benefits today announced the acquisition of My HSA Rewards, an innovative program that allows employees to use cash back from shopping to reduce healthcare costs.

26 Sep 2012

CivaTech Oncology receives NIH/NCI Phase II Contract for CivaSheet device to treat NSCLC

CivaTech Oncology, an RTP medical device company dedicated to developing novel radiation therapy devices, announced the award of a $1M Phase II Contract from the National Institutes of Health and the National Cancer Institute to further develop and commercialize CivaSheet, a bioabsorbable uni-directional device for treatment of non-small-cell lung cancer.

26 Sep 2012

MindChild receives FDA pre-market clearance for MERIDIAN non-invasive fetal heart monitor

MindChild Medical, Inc. today announced that it has received clearance for its Pre-Marketing Notification (510(k)) from the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor.

26 Sep 2012

Universitat de València to use optical technology to prevent myopia

The Universitat de València will use optical technology in order to prevent myopia, which is considered the most common eye disease in the world. Until now, this technology was only used in astronomy to study images of the Universe.

26 Sep 2012

Bruker introduces Toxtyper clinical mass spectrometry solution

At the annual conference of the DGKL, Bruker today announced the European launch of the novel, automated Toxtyper clinical mass spectrometry solution to meet the increasing demands for LC-MS/MS throughput and data quality in routine toxicology laboratories without the need for mass spectrometry expertise.

26 Sep 2012

Technology News and Research

STENTYS announces European commercial release of new Self-Apposing stent technology

Karolinska Institutet scientists discover new approach to treat type II diabetes

Loyola now offers sacral nerve stimulation for patients with fecal incontinence

New optical imaging technology could aid in breast cancer diagnosis and treatment

Prime Healthcare Services purchases Dallas Medical Center

Journal of Vascular and Interventional Radiology debuts new iPad app

CTCA at Midwestern named Certified Quality Breast Center of Excellence

NCI-funded sequencing project aims to identify genetic links to colorectal cancer

Alitair receives U.S. patent allowance for ion exchange resin formulation of benzonatate

Positive results from Sobi, Biogen Idec's rFIXFc Phase 3 trial on hemophilia B

Adult stem cells can prevent Alzheimer's disease

NBSTRN develops new tool for newborn screening researchers

Landec first quarter revenues increase 39% to $102.1 million

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

Tips on safe use of opioids in hospitals

Retail Benefits acquires My HSA Rewards

CivaTech Oncology receives NIH/NCI Phase II Contract for CivaSheet device to treat NSCLC

MindChild receives FDA pre-market clearance for MERIDIAN non-invasive fetal heart monitor

Universitat de València to use optical technology to prevent myopia

Bruker introduces Toxtyper clinical mass spectrometry solution

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News